Investors

Q2 2018 Results

On July 31, Fresenius Medical Care released the results for the second quarter of 2018.

More

Investors

Financial reports

Learn more

Investors

Operating figures

Learn more

Investors

creating ADDED VALUE

Our Annual Report, Corporate Magazine and Company Profile 2017

Learn More
Press release

Anticipated revenue decrease of around 6% on a reported basis and an increase of around 2% on a comparable basis (+3% at constant currency)

Press release

Fresenius Medical Care supports the recommendation by the United Kingdom’s NICE to facilitate population healthcare management for UK patients with end-stage renal disease.

Press release

Healthy organic growth across the board, North American Products business continues strong growth

Fresenius Medical Care Credit Relations

Credit relations

Read more about our main financing instruments, senior notes and the credit ratings.

More
Events
Investor conference
Investor conference

Downloads

Annual Report 2017

PDF , 1.9 MB

Magazine 2017

PDF , 3.2 MB

Annual Report 2017

PDF , 1.9 MB

Magazine 2017

PDF , 3.2 MB

Profile 2017

PDF , 359.6 KB

Annual Report 2017

PDF , 1.9 MB

Magazine 2017

PDF , 3.2 MB

Profile 2017

PDF , 359.6 KB